Gene · 5087
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RSRC2 Expression Inhibits Malignant Progression of Triple-Negative Breast Cancer by Transcriptionally Regulating SCIN Expression. | Cancers (Basel) | 2023 | 38201443 | PubTator, text mining | PubMed |
| Use of Transcriptomics to Reveal the Joint Immunotoxicity Mechanism Initiated by Difenoconazole and Chlorothalonil in the Human Jurkat T-Cell Line. | Foods | 2023 | 38201063 | PubTator, text mining | PubMed |
| [Treatment response of a two-dose regimen of dose-adjusted inotuzumab ozogamicin in relapsed/refractory B-cell acute lymphoblastic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 38185520 | PubTator, text mining | PubMed |
| A Review of Acute Lymphocytic Leukemia (ALL) in the Pediatric Population: Evaluating Current Trends and Changes in Guidelines in the Past Decade. | Cureus | 2023 | 38179374 | PubTator, text mining | PubMed |
| Understanding the role of Pax5 in development of taxane-resistant neuroendocrine like prostate cancers. | Res Sq | 2023 | 38168280 | PubTator, text mining | PubMed |
| Added value of molecular karyotype in childhood acute lymphoblastic leukemia. | Cancer Innov | 2023 | 38125768 | PubTator, text mining | PubMed |
| Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators. | Cell Genom | 2023 | 38116118 | PubTator, text mining | PubMed |
| Novel compound heterozygous pathogenic variants in the SLC3A1 gene in a Chinese family with cystinuria. | BMC Med Genomics | 2023 | 38114997 | PubTator, text mining | PubMed |
| Cellular microenvironment: a key for tuning mesenchymal stem cell senescence. | Front Cell Dev Biol | 2023 | 38111850 | PubTator, text mining | PubMed |
| Cooperative Gsx2-DNA Binding Requires DNA Bending and a Novel Gsx2 Homeodomain Interface. | bioRxiv | 2023 | 38106145 | PubTator, text mining | PubMed |
| t(1;4) translocation in a child with acute lymphoblastic leukemia: a case report. | J Med Case Rep | 2023 | 38082322 | PubTator, text mining | PubMed |
| Molecular Signatures Integral to Natural Reprogramming in the Pigment Epithelium Cells after Retinal Detachment in Pleurodeles waltl. | Int J Mol Sci | 2023 | 38069262 | PubTator, text mining | PubMed |
| Multimodal classification of molecular subtypes in pediatric acute lymphoblastic leukemia. | NPJ Precis Oncol | 2023 | 38066241 | PubTator, text mining | PubMed |
| The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer. | Nat Commun | 2023 | 38057321 | PubTator, text mining | PubMed |
| Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach. | Cell Commun Signal | 2023 | 38031192 | PubTator, text mining | PubMed |
| Diagnostic Yield and Benefits of Whole Exome Sequencing in CAKUT Patients Diagnosed in the First Thousand Days of Life. | Kidney Int Rep | 2023 | 38025229 | PubTator, text mining | PubMed |
| Retrospective analysis of outcomes for pediatric acute lymphoblastic leukemia in South American centers. | Front Oncol | 2023 | 38023200 | PubTator, text mining | PubMed |
| PIWIL1 gene polymorphism and pediatric acute lymphoblastic leukemia relapse susceptibility among Chinese children: a five-center case-control study. | Front Oncol | 2023 | 38023199 | PubTator, text mining | PubMed |
| Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes. | Front Oncol | 2023 | 38023153 | PubTator, text mining | PubMed |
| Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma. | BMC Cancer | 2023 | 38017425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5087/papers?page=8